Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Booth S"'
Autor:
Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Yogev O; The Institute of Cancer Research, London, United Kingdom; and., Martins da Costa B; The Institute of Cancer Research, London, United Kingdom; and., Tubb V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Panetti S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Scarpa U; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Jankevics A; School of Biosciences and Phenome Centre Birmingham and., Lloyd G; School of Biosciences and Phenome Centre Birmingham and., Southam A; School of Biosciences and Phenome Centre Birmingham and., Lee SP; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Dunn WB; School of Biosciences and Phenome Centre Birmingham and., Chesler L; The Institute of Cancer Research, London, United Kingdom; and., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
Blood [Blood] 2020 Sep 03; Vol. 136 (10), pp. 1155-1160.
Autor:
Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Wheat R; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Sarrou E; Paul O'Gorman Leukaemia Research Centre, College of Medicine, Veterinary Life Sciences, Institute of Cancer Sciences, University of Glasgow, United Kingdom., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Stavrou V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Perry T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Kearns P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Cheng P; Bio-cancer Treatment International Ltd, Hong Kong., Keeshan K; Paul O'Gorman Leukaemia Research Centre, College of Medicine, Veterinary Life Sciences, Institute of Cancer Sciences, University of Glasgow, United Kingdom., Craddock C; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
International journal of cancer [Int J Cancer] 2019 Oct 15; Vol. 145 (8), pp. 2201-2208. Date of Electronic Publication: 2019 Jan 11.
Autor:
Fultang L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Gamble LD; Children's Cancer Institute, University of New South Wales, Sydney, Australia., Gneo L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Berry AM; Children's Cancer Research Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Egan SA; School of Veterinary Medicine and Science, Sutton Bonington Campus, University of Nottingham, Nottingham, UK., De Bie F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Yogev O; The Institute of Cancer Research, London, UK., Eden GL; Children's Cancer Institute, University of New South Wales, Sydney, Australia., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Brownhill S; Children's Cancer Research Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Vardon A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., McConville CM; Institute of Cancer Genomic Sciences, University of Birmingham, Birmingham, Birmingham, UK., Cheng PN; Bio-Cancer Treatment International, Hong Kong., Norris MD; Children's Cancer Institute, University of New South Wales, Sydney, Australia., Etchevers HC; GMGF, Aix Marseille University, INSERM, Marseille, France., Murray J; Children's Cancer Institute, University of New South Wales, Sydney, Australia., Ziegler DS; Children's Cancer Institute, University of New South Wales, Sydney, Australia., Chesler L; The Institute of Cancer Research, London, UK., Schmidt R; Sciomics GmbH, Heidelberg, Germany., Burchill SA; Children's Cancer Research Group, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds, UK., Haber M; Children's Cancer Institute, University of New South Wales, Sydney, Australia., De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. francis.mussai@nhs.net.
Publikováno v:
Cancer research [Cancer Res] 2019 Feb 01; Vol. 79 (3), pp. 611-624. Date of Electronic Publication: 2018 Dec 13.
Autor:
De Santo C; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Booth S; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Vardon A; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Cousins A; Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom., Tubb V; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom., Perry T; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Noyvert B; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Beggs A; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Ng M; Department of Anatomic Pathology, The Chinese University of Hong Kong, Hong Kong., Halsey C; Institute of Cancer Sciences, Wolfson Wohl Cancer Research Centre, College of Medical, Veterinary and Life Sciences, University of Glasgow, United Kingdom., Kearns P; Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom., Cheng P; Bio-Cancer Treatment International Ltd, Hong Kong., Mussai F; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Publikováno v:
International journal of cancer [Int J Cancer] 2018 Apr 01; Vol. 142 (7), pp. 1490-1502. Date of Electronic Publication: 2017 Dec 26.
Autor:
Soutar AK; Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, United Kingdom., Hawkins PN, Vigushin DM, Tennent GA, Booth SE, Hutton T, Nguyen O, Totty NF, Feest TG, Hsuan JJ, et. al.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 1992 Aug 15; Vol. 89 (16), pp. 7389-93.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.